Charles Schwab Investment Management Inc Vericel Corp Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vericel Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 428,702 shares of VCEL stock, worth $23.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
428,702
Previous 426,578
0.5%
Holding current value
$23.1 Million
Previous $22.2 Million
11.37%
% of portfolio
0.0%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding VCEL
# of Institutions
274Shares Held
48.9MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$435 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$239 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$186 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$134 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$112 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.55B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...